Revision Skincare® Announces Two Peer‑Reviewed Clinical Studies Demonstrating the Cosmetic Benefits of THD Ascorbate in C+ Correcting Complex 30%®

IRVING, Texas, Apr. 9, 2026 /PRNewswire/ -- Revision Skincare®, a physician‑dispensed medical‑grade skincare company focused on clinically validated innovation, today announced the publication of two peer‑reviewed clinical studies in the Journal of Cosmetic Dermatology. The studies...